Work

Human papilloma virus–specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patients

Year: 2018

Type: article

Source: Cytotherapy

DOI: 10.1016/j.jcyt.2017.11.010

Authors: Sarah E. McCormack, Conrad Russell Y. Cruz, Kaylor E. Wright, Allison B. Powell, Haili Lang, Cornelia Trimble, Michael D. Keller, Ephraim Fuchs, Catherine M. Bollard

Institutions: Children's National, Johns Hopkins University, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Johns Hopkins University, National Cancer Institute

Awards: Novel Cord Blood-Derived Cellular Therapies, SPORE in Cervical Cancer

OpenAlex ID: W2783392307

FWCI: 0.859

Cites: 46

Cited by: 15

Related to: 10